DXCM vs YEXT · P/E 63, rev $2.50B vs P/E 48, rev $446.6M
DexCom Inc (DXCM) versus Yext Inc (YEXT) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Yext Inc (YEXT) is a software - infrastructure company listed on NYSE.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported YEXT revenue for 2026-01-31 was $446.6M. Net income was $37.9M. Revenue was up 6.1% from 2025-01-31 to 2026-01-31. YEXT currently screens at market cap $381.9M and trailing P/E 47.6.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. YEXT currently screens at market cap $381.9M and trailing P/E 47.6.
Not investment advice. Open the DXCM and YEXT stock pages for the full models.
Not investment advice.